<DOC>
	<DOCNO>NCT02990182</DOCNO>
	<brief_summary>In previous study researcher ' group , researcher ' investigate duration yellow fever post-vaccination immunity vaccinate child 9 23 month age . However , study , sample child pre-vaccine period , also know unvaccinated child sample ( NV ) investigate . It believe seek evidence immune status medium long term vaccination yellow fever necessary investigate pair sample child vaccinate ( NV ) , re-evaluation 30-45 day primary vaccination . The propose study consolidate aspect humoral ( neutralize antibody ) cellular ( phenotypic functional parameter T cell memory B ) mean complementary longitudinal investigation child , 9-23 month old , unvaccinated ( NV ) 30-45 day primary vaccination .</brief_summary>
	<brief_title>Complementary Study Duration Post-vaccination Against Yellow Fever Immunity Children</brief_title>
	<detailed_description>A sample 60 child age 9 23 month pair pre-vaccine period ( NV ) 30-45 post-primary vaccination day select health facility metropolitan region Belo Horizonte . Children whose mother consent participate research , collect blood element past medical history record . Analyses humoral cellular biomarkers use comparative study post-vaccination period previously analyze child first phase study fund Ministry Health . specific objective : 1 . Estimate compare proportion positivity geometric mean plasma titer neutralize antibody yellow fever ; 2 . Assess lymphocyte frequency T B memory induce vitro vaccine antigen 17DD substrains , ... 3 . Quantify lymphocytes T CD8 + producer intracytoplasmic cytokine induce vitro vaccine antigen 17DD substrains unvaccinated child prim age 9 23 month , categorize accord vaccination time 30-45 day .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Yellow Fever</mesh_term>
	<criteria>Will eligible study : child 923 month age ; sex ; child vaccinate yellow fever , whose parent guardians sign consent form . child receive another vaccine within 30 day yellow fever vaccine ; child permanent temporary immunosuppression , include treated corticosteroid dose high 2 mg / kg , disease autoimmune disease , transient permanent immunosuppression induce disease ( cancer , AIDS , etc . ) treatment ( immunosuppressive drug , radiotherapy , etc. ) . Corticosteroids ( prednisone , dexamethasone ) less two week , inhalation topical use , indicate exclusion study , must register questionnaire ( Annex II ) ; child hemoglobinopathy ; child history blood transfusion treatment hyperimmune serum 90 day prior blood collection .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Yellow Fever Vaccine</keyword>
	<keyword>Immunity , Humoral</keyword>
	<keyword>Immunity , Cellular</keyword>
	<keyword>child</keyword>
</DOC>